Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Cytokinetics IncCYTK | +98.10% | $32.71 | $64.80 | 2023-08-14 - 2024-04-25 | Buy |
Xeris Biopharma Holdings IncXERS | +97.62% | $1.26 | $2.49 | 2023-01-26 - 2024-01-26 | Buy |
Myovant Sciences LtdMYOV | +60.19% | $16.68 | $26.72 | 2022-08-08 - 2022-10-25 | Buy |
Lantheus Holdings IncLNTH | +25.00% | $70.08 | $87.60 | 2022-06-05 - 2023-06-05 | Buy |
Scpharmaceuticals IncSCPH | +18.39% | $5.60 | $6.63 | 2022-10-10 - 2023-10-10 | Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Ardelyx IncARDX | 1 | Buy | $14.00 | +121.87% | Initiates Coverage On | 21 days ago |
Ars Pharmaceuticals IncSPRY | 2 | Buy | $18.00 | +122.50% | Upgrades | 2 months ago |
United Therapeutics CorpUTHR | 1 | Buy | $330.00 | +39.86% | Initiates Coverage On | 3 months ago |
Cytokinetics IncCYTK | 1 | Buy | $58.00 | -10.49% | Initiates Coverage On | 8 months ago |
Corcept Therapeutics IncCORT | 1 | Hold | $25.00 | N/A | Initiates Coverage On | a year ago |
Pardes Biosciences IncPRDS | 4 | Hold | $2.00 | N/A | Downgrades | a year ago |
Enanta Pharmaceuticals IncENTA | 10 | Hold | $49.00 | N/A | Reiterates | a year ago |
Xeris Biopharma Holdings IncXERS | 4 | Buy | $5.00 | N/A | Maintains | a year ago |
Vir Biotechnology IncVIR | 3 | Buy | $43.00 | N/A | Maintains | a year ago |
Scpharmaceuticals IncSCPH | 5 | Buy | $13.00 | N/A | Maintains | a year ago |
Atea Pharmaceuticals IncAVIR | 6 | Hold | $6.00 | N/A | Maintains | a year ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $19.00 | N/A | Initiates Coverage On | a year ago |
Lantheus Holdings IncLNTH | 3 | Buy | $120.00 | N/A | Maintains | a year ago |
Aligos Therapeutics IncALGS | 7 | Hold | $2.00 | N/A | Maintains | a year ago |
Myovant Sciences LtdMYOV | 7 | Hold | $27.00 | N/A | Downgrades | 2 years ago |
Amarin Corp PLCAMRN | 5 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Contrafect CorpCFRXQ | 3 | Hold | $80.00 | N/A | Downgrades | 2 years ago |